| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 5.2% stake in Eventbrite, Inc. |
| 02/14/2022 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 0% stake in Radware Ltd. |
| 02/14/2022 |
SC 13G
| CADIAN CAPITAL MANAGEMENT, LP reports a 6.7% stake in TCV Acquisition Corp. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 7.6% stake in Zogenix, Inc. |
| 02/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/12/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/13/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/14/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/12/2021 |
SC 13G
| CADIAN CAPITAL MANAGEMENT, LP reports a 9.5% stake in Zogenix, Inc. |
| 02/12/2021 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 3.2% stake in Varonis Systems, Inc. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 0% stake in NanoString Technologies, Inc. |
| 02/12/2021 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 0% stake in GenMark Diagnostics, Inc. |
| 11/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 9.5% stake in GenMark Diagnostics, Inc. |
| 02/13/2020 |
SC 13G
| CADIAN CAPITAL MANAGEMENT, LP reports a 6.2% stake in Varonis Systems, Inc. |
| 02/13/2020 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 2.7% stake in Portola Pharmaceuticals, Inc. |
| 02/13/2020 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 4.9% stake in Zogenix, Inc. |
| 02/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
|